Furthermore, the influence of genetic background on the predisposition to BCR::ABL1-negative MPNs has been suggested in studies with large cohorts and familial BCR::ABL1-negative MPN pedigrees [18,19]. Here, ABL1 is linked to myeloproliferative disorder.